Literature DB >> 7979441

Abnormal skin irritancy in atopic dermatitis and in atopy without dermatitis.

A Nassif1, S C Chan, F J Storrs, J M Hanifin.   

Abstract

BACKGROUND AND
DESIGN: Past observations have shown increased irritancy in patients with "conditioned hyperirritability" due to active dermatitis, including atopic dermatitis (AD). In less active atopic conditions, irritancy levels are less certain. We have utilized 48-hour Finn Chamber testing with graded dilutions of sodium lauryl sulfate to detect irritancy thresholds in well-defined groups of patients with AD, inactive AD, and allergic respiratory disease with no dermatitis and in normal nonatopic subjects.
RESULTS: Significantly greater frequency of response to sodium lauryl sulfate in both AD groups and also in patients with allergic rhinitis with no dermatitis was seen. Effective concentrations of sodium lauryl sulfate causing irritation in 50% or more of subjects (ED50) ranged from 0.0625% to 0.31% in all atopic groups, percentages that were significantly lower than the normal ED50 of 0.60%. Response intensity was also significantly greater in each atopic group.
CONCLUSIONS: Our results showed significantly greater irritant responses in atopic subjects with no skin disease or in subjects with inactive AD and confirmed past findings that showed greatly increased irritancy in patients with active AD. We hypothesize that abnormal intrinsic hyperreactivity in inflammatory cells, rather than in skin cells, in atopic individuals predisposes to a lowered threshold of irritant responsiveness.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7979441

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  13 in total

Review 1.  Eyelid dermatitis.

Authors:  V S Beltrani
Journal:  Curr Allergy Asthma Rep       Date:  2001-07       Impact factor: 4.806

Review 2.  The role of patch testing for chemical and protein allergens in atopic dermatitis.

Authors:  S T Nedorost; K D Cooper
Journal:  Curr Allergy Asthma Rep       Date:  2001-07       Impact factor: 4.806

Review 3.  The spectrum of cutaneous patch-test reactions in patients with atopic dermatitis.

Authors:  J M Hanifin; P A Klas
Journal:  Clin Rev Allergy Immunol       Date:  1996       Impact factor: 8.667

Review 4.  Contact dermatitis. Clinical perspectives and basic mechanisms.

Authors:  A Nasir; A A Gaspari
Journal:  Clin Rev Allergy Immunol       Date:  1996       Impact factor: 8.667

Review 5.  Environmental risk factors and their role in the management of atopic dermatitis.

Authors:  Robert Kantor; Jonathan I Silverberg
Journal:  Expert Rev Clin Immunol       Date:  2016-07-28       Impact factor: 4.473

Review 6.  Atopic dermatitis results in intrinsic barrier and immune abnormalities: implications for contact dermatitis.

Authors:  Julia K Gittler; James G Krueger; Emma Guttman-Yassky
Journal:  J Allergy Clin Immunol       Date:  2012-08-28       Impact factor: 10.793

7.  Topical doxycycline monohydrate hydrogel 1% targeting proteases/PAR2 pathway is a novel therapeutic for atopic dermatitis.

Authors:  Mary Bohannon; Mingjin Liu; Peter Nadeau; Judy Talton; Daniel Gibson; Susmita Datta; Gregory Schultz; James Talton; Anna De Benedetto
Journal:  Exp Dermatol       Date:  2020-10-15       Impact factor: 3.960

8.  Resident skin-specific gammadelta T cells provide local, nonredundant regulation of cutaneous inflammation.

Authors:  Michael Girardi; Julia Lewis; Earl Glusac; Renata B Filler; Liping Geng; Adrian C Hayday; Robert E Tigelaar
Journal:  J Exp Med       Date:  2002-04-01       Impact factor: 14.307

Review 9.  Disease Mechanisms in Atopic Dermatitis: A Review of Aetiological Factors.

Authors:  Jacob P Thyssen; Maria Rasmussen Rinnov; Christian Vestergaard
Journal:  Acta Derm Venereol       Date:  2020-06-09       Impact factor: 3.875

10.  Response to Nonallergenic Irritants in Children With Allergic and Nonallergic Rhinitis.

Authors:  Ji Hyeon Baek; Eunhae Cho; Mi Ae Kim; Seung Won Lee; Yu Sun Kang; Youn Ho Sheen; Hye Mi Jee; Young Ho Jung; Man Yong Han
Journal:  Allergy Asthma Immunol Res       Date:  2016-07       Impact factor: 5.764

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.